Yüklüyor......
Teneligliptin in management of type 2 diabetes mellitus
Teneligliptin is a recently developed oral dipeptidyl peptidase 4 inhibitor indicated for the management of type 2 diabetes mellitus (T2DM) in adults along with diet and exercise. Teneligliptin has been recently available in Japan (Teneria(®)), Argentina (Teneglucon(®)), and India (Tenepure; Teneza)...
Kaydedildi:
| Yayımlandı: | Diabetes Metab Syndr Obes |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4993264/ https://ncbi.nlm.nih.gov/pubmed/27574456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S106133 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|